Human Monoclonal Anti-Protective Antigen Antibody for the Low-Dose Post-Exposure Prophylaxis and Treatment of Anthrax
BMC Infectious Diseases - United Kingdom
doi 10.1186/s12879-018-3542-6
Full Text
Open PDFAbstract
Available in full text
Categories
Date
December 1, 2018
Authors
Publisher
Springer Science and Business Media LLC